<DOC>
	<DOCNO>NCT01831011</DOCNO>
	<brief_summary>Mildronate inhibitor carnitine-dependent metabolism , consider anti-ischemic drug . This study aim evaluate efficacy safety mildronate injection treat acute ischemic stroke .</brief_summary>
	<brief_title>Mildronate Acute Ischemic Stroke</brief_title>
	<detailed_description>A randomized , double-blind , multi-center clinical study make mildronate injection treat acute cerebral infarction . 113 case experimental group give mildronate injection , 114 case active-control group give cinepazide maleate injection . In addition , group give aspirin basic treatment . Modified Rankin Scale ( mRS ) score 2 week 3 month , National Institutes Health Stroke Scale ( NIHSS ) score Barthel Index score 2 week treatment , vital sign adverse event evaluate .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>3- ( 2,2,2-trimethylhydrazine ) propionate</mesh_term>
	<criteria>( ) clinical diagnosis acute ischaemic stroke , first episode within previous 7 day , confirm CT MRI brain imaging . ( ii ) 18 80 year age ( patient &gt; = 70 year combine poor physical condition except ischaemic stroke ) ( iii ) score 522 National Institutes Health Stroke Scale ( NIHSS ) . ( iv ) report liver kedney function less 1.5 fold normal value . ( ) intracranial pathology ( e.g . cerebral hemorrhage , tumour , infection ) , ( ii ) pregnant nursing ; ( iii ) neurological psychiatric disease ; ( iv ) significant drug alcohol misuse , ( v ) give thrombolytic therapy medication forbidden study protocol ; ( vi ) participate clinical trial past 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>randomize trial</keyword>
	<keyword>acute ischemic stroke</keyword>
	<keyword>mildronate</keyword>
</DOC>